Neuren Media and Analyst Coverage, page-1214

So here we have a statement from Hottod that Neuren doesnt have to seek approval for its undisclosed indications. However, should a dispute arise concerning these undisclosed indications Acadia would ultimately have final say on whether Neuren can proceed with them. Which in turn makes the other points Hottod made irrelevant because if a dispute could not be resolved all of these clauses and responsibilities would get swept aside with Acadia having final say. So it is true, from a certain point of view, that Neuren will ultimately need to clear these undisclosed indications with Acadia because as soon as they say no, Neuren doesnt have a leg to stand on. There is no contractual obligation to seek approval, but power is in Acadia's hands to deny Neuren.

I think it's contradictory to make your interpretation of the agreement known publicly and then use the agreement to argue points against another poster who is in fact saying the same thing as what you have been saying. Its a pedantic approach that doesnt fit your wider view.